Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Ilepatril
Cat. No.:
OB0425LY-171
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Ilepatril is an endogenous enzyme inhibitor and affects the metabolism of amino acids and fatty acids in the body.
Synonyms:
473289-62-2; AVE7688; (4S,7S,12bR)-7-[[(2S)-2-Acetylsulfanyl-3-methylbutanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid; (2R,6S,9S)-9-((2S)-2-(Acetylsulfanyl)-3-methylbutanamido)-8-oxo-7-azatricyclo(9.4.0.02,7)pentadeca-1(11),12,14-triene-6-carboxylic acid
CAS No.:
473289-62-2
Compound CID:
9824131
Formula:
C22H28N2O5S
Formula Weight:
432.53
Specification
Target:
Angiotensin-converting enzyme (ACE)
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
Ilepatril can be used to study nephropathy in diabetic rats.
